Showing 61 - 80 results of 225 for search '"Blood–brain barrier"', query time: 0.06s Refine Results
  1. 61

    miRNAs Participate in MS Pathological Processes and Its Therapeutic Response by Ting Wu, Guangjie Chen

    Published 2016-01-01
    “…It is believed that the increased migration of autoreactive lymphocytes across the blood-brain barrier (BBB) may be responsible for axonal demyelination of neurons. …”
    Get full text
    Article
  2. 62

    Efficacy of human umbilical cord mesenchymal stem cell in the treatment of neuromyelitis optica spectrum disorders: an animal study by Chunran Xue, Haojun Yu, Xuzhong Pei, Xiaoying Yao, Jie Ding, Xiying Wang, Yi Chen, Yangtai Guan

    Published 2025-02-01
    “…Conclusion Our results revealed that hUC-MSCs displayed therapeutic efficacy in NMOSD and showed potential in attenuating blood–brain barrier disruption, as well as AQP4 IgG and complement-induced astrocyte apoptosis.…”
    Get full text
    Article
  3. 63

    Parkinson’s disease and exosomes: from pathogenesis to diagnosis and treatment by A. Mišeikaitė, P. Vaitkienė

    Published 2021-06-01
    “…There is growing evidence of the importance of exosomes for cell-to-cell communication, mediating the exchange of biological information and substances, and the ability to cross the blood-brain barrier. Due to their ability to cross the blood-brain barrier, exosomes may be promising for drug or molecular transportation and help in the development of more effective treatments for PD and other diseases of the nervous system. …”
    Get full text
    Article
  4. 64

    Matrix Metalloproteinases in patients with Multiple Sclerosis. by Rebeca A. Fernández Carriera, Lourdes Fernández Queija, Rosa F. Lara Rodríguez, José Cabrera Gómez, Idalmis Suárez Luis, Mabel María León Ortiz, Sergio González García, Alina González-Quevedo Monteagudo

    Published 2007-05-01
    “…<strong>Fundament:</strong> The proteolitic rupture of the extracellular matrix due to metalloproteinase 2 and 9 is one of the aspects that can influence in the alteration of the permeability of the blood-brain barrier (BBB) in multiple sclerosis. <strong>Objective:</strong> To determine metalloproteinase activity with gelatinous activity in patients suffering from multiple sclerosis. …”
    Get full text
    Article
  5. 65

    Posterior Reversible Encephalopathy Syndrome as Presenting Form of Very Early Systemic Sclerosis by María Isabel Pedraza, Julia Barbado, Marina Ruiz, Ángel Luis Guerrero

    Published 2015-01-01
    “…Its mechanism depends on failure of the blood-brain barrier due to high systemic blood pressure (BP) and loss of integrity of vascular endothelium related with different triggers. …”
    Get full text
    Article
  6. 66

    Esophageal Gastrointestinal Stromal Tumor with Rare Intracranial Metastasis by José Carvalho, Margarida Teixeira, Francisco Teixeira Silva, Alexandra Esteves, Carlos Ribeiro, Diana Guerra

    Published 2020-01-01
    “…New tyrosine kinase inhibitors that may cross the blood-brain barrier could be the answer to these cases.…”
    Get full text
    Article
  7. 67

    A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats by Menuka M. Pallebage-Gamarallage, Virginie Lam, Ryusuke Takechi, Susan Galloway, John C. L. Mamo

    Published 2012-01-01
    “…Chronic ingestion of saturated fatty acids (SFAs) was previously shown to compromise blood-brain barrier integrity, leading to brain parenchymal extravasation of apolipoprotein B (apo B) lipoproteins enriched in amyloid beta. …”
    Get full text
    Article
  8. 68

    Application of the Box–Behnken Design in the Development of Amorphous PVP K30–Phosphatidylcholine Dispersions for the Co-Delivery of Curcumin and Hesperetin Prepared by Hot-Melt Ex... by Kamil Wdowiak, Lidia Tajber, Andrzej Miklaszewski, Judyta Cielecka-Piontek

    Published 2024-12-01
    “…In vitro permeability across the gastrointestinal tract and blood–brain barrier was evaluated using the parallel artificial membrane permeability assay. …”
    Get full text
    Article
  9. 69

    Systematic Study of Steroid Drugs’ Ability to Cross Biomembranes—The Possible Environmental Impact and Health Risks Associated with Exposure During Pregnancy by Anna W. Sobańska, Aleksandra Orlikowska, Karolina Famulska, Lovro Bošnjak, Domagoj Bosiljevac, Aleksandra Rasztawicka, Andrzej M. Sobański

    Published 2024-12-01
    “…Thirty-seven steroid drugs of different types were investigated in silico for their environmental and pharmacokinetic properties (partition between soil and water, bioaccumulation in aquatic organisms, ability to be absorbed from the gastrointestinal tract and to cross biological barriers—skin, blood–brain barrier and placenta) using on-line tools and novel QSAR models. …”
    Get full text
    Article
  10. 70

    Disseminated Histoplasmosis with Miliary Histoplasmosis, Neurohistoplasmosis, and Histoplasma capsulatum Bacteremia in Probable Neurosarcoidosis by Peter V. Bui

    Published 2018-01-01
    “…Patients with neurosarcoidosis are suspected to have blood-brain barrier dysfunction. Lumbar puncture should be considered as part of initial investigative studies for infection. …”
    Get full text
    Article
  11. 71

    Chemokines and Chemokine Receptors in Multiple Sclerosis by Wenjing Cheng, Guangjie Chen

    Published 2014-01-01
    “…The migration of autoimmune T cells and macrophages from blood to central nervous system as well as the destruction of blood brain barrier are thought to be the major processes in the development of this disease. …”
    Get full text
    Article
  12. 72

    The Role of C1-Esterase Inhibitors in the Management of Vasogenic Edema in Glioblastoma by Gillian R. Naro, Nicholas Noverati, Timothy Craig

    Published 2020-01-01
    “…As the tumor grows and disrupts the blood-brain barrier (BBB), vasogenic edema can result. The edema has the potential to significantly contribute to a patient’s morbidity and mortality. …”
    Get full text
    Article
  13. 73

    Isolated Central Nervous System Involvement after Brentuximab Vedotin Treatment for HIV-Positive ALK-Negative Anaplastic Large Cell Lymphoma by Takuya Suyama, Kumiko Matsui, Kosuke Makihara, Masatoshi Tsuru

    Published 2024-01-01
    “…Herein, we present a case of HIV-associated ALCL with isolated CNS involvement that occurred following the discontinuation of ART that was administered after treatment with brentuximab vedotin (BV)—which does not cross the blood-brain barrier. At the time of CNS recurrence, the patient’s CD4 count was 9 cells/mm3. …”
    Get full text
    Article
  14. 74

    Receptor-Mediated Endocytosis and Brain Delivery of Therapeutic Biologics by Guangqing Xiao, Liang-Shang Gan

    Published 2013-01-01
    “…Transport of macromolecules across the blood-brain-barrier (BBB) requires both specific and nonspecific interactions between macromolecules and proteins/receptors expressed on the luminal and/or the abluminal surfaces of the brain capillary endothelial cells. …”
    Get full text
    Article
  15. 75

    Postmortem Cerebrospinal Fluid Pleocytosis: A Marker of Inflammation or Postmortem Artifact? by James A. Morris, Linda M. Harrison, David R. Telford

    Published 2012-01-01
    “…There is theoretical and experimental evidence that the blood brain barrier to the movement of protein and cells is preserved in the first few hours after death. …”
    Get full text
    Article
  16. 76

    Immune Privilege as an Intrinsic CNS Property: Astrocytes Protect the CNS against T-Cell-Mediated Neuroinflammation by Ulrike Gimsa, N. Avrion Mitchison, Monika C. Brunner-Weinzierl

    Published 2013-01-01
    “…They are responsible for formation of the blood-brain barrier (BBB) and make up the glia limitans. …”
    Get full text
    Article
  17. 77

    Lessons from a Mouse Model Characterizing Features of Vascular Cognitive Impairment with White Matter Changes by Masafumi Ihara, Hidekazu Tomimoto

    Published 2011-01-01
    “…The purpose of this paper is to provide a comprehensive summary of the achievements made with the model that shows good reproducibility of the white matter changes characterized by blood-brain barrier disruption, glial activation, oxidative stress, and oligodendrocyte loss following chronic cerebral hypoperfusion. …”
    Get full text
    Article
  18. 78

    Melatonin in Hypoxic-Ischemic Brain Injury in Term and Preterm Babies by Justyna Paprocka, Marek Kijonka, Beata Rzepka, Maria Sokół

    Published 2019-01-01
    “…Melatonin efficacy, low toxicity, and ability to readily cross through the blood-brain barrier make it a promising molecule. A very interesting thing is the difference between the half-life of melatonin in preterm neonates (15 hours) and adults (45-60 minutes). …”
    Get full text
    Article
  19. 79

    Transport of Alzheimer's associated amyloid-β catalyzed by P-glycoprotein. by James W McCormick, Lauren McCormick, Gang Chen, Pia D Vogel, John G Wise

    Published 2021-01-01
    “…P-glycoprotein (P-gp) is a critical membrane transporter in the blood brain barrier (BBB) and is implicated in Alzheimer's disease (AD). …”
    Get full text
    Article
  20. 80

    Gene Therapy for Glioblastoma Multiforme by Smit Shah, Joshua Green, Shantelle A. Graff, Qi Li, John D. Heiss

    Published 2025-01-01
    “…Significant limitations to effective GBM treatment include poor drug delivery across the blood–brain barrier, drug resistance, and complex genetic tumor alterations. …”
    Get full text
    Article